Protara Therapeutics, Inc.
US ˙ NasdaqGM ˙ US74365U1079

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Barry P Flannelly. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Barry P Flannelly har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:INCY / Incyte Corporation EVP & General Manager US 35.149
US:TARA / Protara Therapeutics, Inc. Director 10.000
US:GHDX / Genomic Health, Inc. Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Barry P Flannelly. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb TARA / Protara Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TARA / Protara Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TARA / Protara Therapeutics, Inc. Insider Trades
Insidersalg TARA / Protara Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TARA / Protara Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TARA / Protara Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Barry P Flannelly som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-07-17 2025-07-16 4 INCY INCYTE CORP
Common Stock
S - Sale -1.340 35.149 -3,67 68,36 -91.602 2.402.786
2025-07-16 2025-07-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -1.141 36.489 -3,03 68,25 -77.873 2.490.374
2025-07-16 2025-07-15 4 INCY INCYTE CORP
Common Stock
S - Sale -1.192 37.630 -3,07 69,86 -83.273 2.628.832
2025-07-16 2025-07-14 4 INCY INCYTE CORP
Common Stock
F - Taxes -922 38.822 -2,32 69,98 -64.522 2.716.764
2025-07-07 2025-07-03 4 INCY INCYTE CORP
Common Stock
S - Sale -10.903 39.744 -21,53 68,15 -743.039 2.708.554
2025-07-07 2025-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -9.055 50.647 -15,17 68,17 -617.279 3.452.606
2025-04-03 2025-04-01 4 INCY INCYTE CORP
Common Stock
A - Award 14.976 59.702 33,48
2025-04-03 2025-04-01 4 INCY INCYTE CORP
Common Stock
A - Award 11.159 44.726 33,24
2025-03-18 2025-03-14 4 INCY INCYTE CORP
Common Stock
S - Sale -19.147 33.567 -36,32 67,68 -1.295.869 2.271.815
2025-03-18 2025-03-14 4 INCY INCYTE CORP
Common Stock
S - Sale -199 52.714 -0,38 67,88 -13.508 3.578.226
2025-03-18 2025-03-14 4 INCY INCYTE CORP
Common Stock
S - Sale -461 52.913 -0,86 67,85 -31.279 3.590.147
2025-01-17 2025-01-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -3.158 53.374 -5,59 72,46 -228.829 3.867.480
2024-12-11 2024-12-09 4 INCY INCYTE CORP
Common Stock
F - Taxes -1.510 56.532 -2,60 72,11 -108.886 4.076.523
2024-11-08 2024-11-06 4 INCY INCYTE CORP
Common Stock
S - Sale -2.256 58.042 -3,74 78,21 -176.442 4.539.465
2024-11-08 2024-11-06 4 INCY INCYTE CORP
Common Stock
S - Sale -1.424 60.298 -2,31 82,00 -116.768 4.944.436
2024-11-08 2024-11-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.256 61.722 3,79 68,62 154.807 4.235.364
2024-11-08 2024-11-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 1.424 59.466 2,45 72,27 102.912 4.297.608
2024-07-17 2024-07-16 4 INCY INCYTE CORP
Common Stock
S - Sale -1.306 58.042 -2,20 64,19 -83.832 3.725.716
2024-07-17 2024-07-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -1.111 59.348 -1,84 64,25 -71.382 3.813.109
2024-07-17 2024-07-15 4 INCY INCYTE CORP
Common Stock
A - Award 9.925 60.459 19,64
2024-07-11 2024-07-09 4 INCY INCYTE CORP
Common Stock
S - Sale -8.148 50.534 -13,89 60,00 -488.880 3.032.040
2024-07-03 2024-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -7.695 58.682 -11,59 59,02 -454.159 3.463.412
2024-06-14 2024-06-12 4 INCY INCYTE CORP
Common Stock
S - Sale -19.164 66.377 -22,40 60,00 -1.149.840 3.982.620
2024-02-16 2024-02-14 4 INCY INCYTE CORP
Common Stock
A - Award 7.377 85.080 9,49
2024-01-19 2024-01-17 4 INCY INCYTE CORP
Common Stock
F - Taxes -3.675 77.703 -4,52 61,48 -225.939 4.777.180
2023-07-18 2023-07-14 4 INCY INCYTE CORP
Common Stock
A - Award 9.668 81.378 13,48
2023-07-06 2023-07-03 4 INCY INCYTE CORP
Common Stock
F - Taxes -6.304 71.710 -8,08 62,08 -391.352 4.451.757
2023-01-24 2023-01-20 4 INCY INCYTE CORP
Common Stock
A - Award 4.980 77.654 6,85
2022-07-11 2022-07-07 4 INCY INCYTE CORP
Common Stock
S - Sale X -2.873 72.674 -3,80 79,38 -228.059 5.768.862
2022-07-06 2022-07-05 4 INCY INCYTE CORP
Common Stock
F - Taxes -3.506 75.547 -4,43 79,25 -277.850 5.987.100
2022-07-06 2022-07-02 4 INCY INCYTE CORP
Common Stock
A - Award 13.529 79.053 20,65
2022-04-12 2022-04-08 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -21.348 0 -100,00
2022-04-12 2022-04-08 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -20.516 0 -100,00
2022-04-12 2022-04-08 4 INCY INCYTE CORP
Common Stock
S - Sale -1.248 65.163 -1,88 82,96 -103.534 5.405.922
2022-04-12 2022-04-08 4 INCY INCYTE CORP
Common Stock
S - Sale -881 66.411 -1,31 82,96 -73.088 5.509.457
2022-04-12 2022-04-08 4 INCY INCYTE CORP
Common Stock
S - Sale -21.348 67.292 -24,08 84,00 -1.793.232 5.652.528
2022-04-12 2022-04-08 4 INCY INCYTE CORP
Common Stock
M - Exercise 21.348 88.640 31,72 72,27 1.542.820 6.406.013
2022-04-12 2022-04-08 4 INCY INCYTE CORP
Common Stock
S - Sale -20.516 67.292 -23,36 83,01 -1.703.033 5.585.909
2022-04-12 2022-04-08 4 INCY INCYTE CORP
Common Stock
M - Exercise 20.516 87.808 30,49 68,62 1.407.808 6.025.385
2022-01-21 2022-01-19 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 15.054 15.054
2022-01-05 2022-01-01 4 INCY INCYTE CORP
Common Stock
A - Award 8.678 67.292 14,81
2021-11-23 2021-11-19 4 INCY INCYTE CORP
Common Stock
A - Award 2.355 58.614 4,19
2021-11-23 2021-11-19 4 INCY INCYTE CORP
Common Stock
A - Award 379 56.259 0,68
2021-07-07 2021-07-06 4 INCY INCYTE CORP
Common Stock
F - Taxes -273 55.880 -0,49 83,34 -22.752 4.657.039
2021-07-07 2021-07-02 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 15.054 15.054
2021-07-07 2021-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -1.990 56.153 -3,42 83,58 -166.324 4.693.268
2021-07-07 2021-07-02 4 INCY INCYTE CORP
Common Stock
A - Award 7.853 58.143 15,62
2021-06-10 2021-06-09 4 TARA Protara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2021-01-27 2021-01-25 4 INCY INCYTE CORP
Common Stock
S - Sale X -2.744 49.994 -5,20 100,00 -274.400 4.999.400
2021-01-20 2021-01-15 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 12.743 12.743
2021-01-20 2021-01-15 4 INCY INCYTE CORP
Common Stock
A - Award 11.522 52.738 27,96
2020-11-18 2020-11-16 4 INCY INCYTE CORP
Common Stock
A - Award 1.232 41.216 3,08
2020-11-04 2020-11-02 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2020-11-04 2020-11-02 4 INCY INCYTE CORP
Common Stock
S - Sale -20.000 39.984 -33,34 86,60 -1.732.000 3.462.614
2020-11-04 2020-11-02 4 INCY INCYTE CORP
Common Stock
M - Exercise 20.000 59.984 50,02 48,44 968.800 2.905.625
2020-07-27 2020-07-23 4 TARA Protara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 8.250 26.250 45,83
2020-07-27 2020-07-23 4 TARA Protara Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 18.000 18.000
2020-07-17 2020-07-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -639 39.903 -1,58 104,25 -66.616 4.159.888
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
F - Taxes -404 40.542 -0,99 107,79 -43.547 4.370.022
2020-07-07 2020-07-02 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 12.743 12.743
2020-07-07 2020-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -1.776 40.946 -4,16 106,47 -189.091 4.359.521
2020-07-07 2020-07-02 4 INCY INCYTE CORP
Common Stock
A - Award 6.661 42.722 18,47
2020-06-25 2020-06-23 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -599 0 -100,00
2020-06-25 2020-06-23 4 INCY INCYTE CORP
Common Stock
S - Sale -400 36.061 -1,10 110,00 -44.000 3.966.710
2020-06-25 2020-06-23 4 INCY INCYTE CORP
Common Stock
M - Exercise 599 36.461 1,67 73,21 43.853 2.669.310
2020-06-23 2020-06-19 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7.181 0 -100,00
2020-06-23 2020-06-19 4 INCY INCYTE CORP
Common Stock
S - Sale -7.181 35.862 -16,68 105,00 -754.005 3.765.510
2020-06-23 2020-06-19 4 INCY INCYTE CORP
Common Stock
M - Exercise 7.181 43.043 20,02 73,21 525.721 3.151.178
2020-04-21 2020-04-17 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -6.583 7.181 -47,83
2020-04-21 2020-04-17 4 INCY INCYTE CORP
Common Stock
S - Sale -6.583 35.342 -15,70 100,00 -658.300 3.534.200
2020-04-21 2020-04-17 4 INCY INCYTE CORP
Common Stock
M - Exercise 6.583 41.925 18,63 73,21 481.941 3.069.329
2020-02-18 2020-02-13 4 INCY INCYTE CORP
Common Stock
A - Award 6.881 35.342 24,18
2020-01-22 2020-01-17 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 16.428 16.428
2020-01-22 2020-01-17 4 INCY INCYTE CORP
Common Stock
A - Award 11.482 28.461 67,62
2019-12-03 2019-12-02 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -6.582 13.764 -32,35
2019-12-03 2019-12-02 4 INCY INCYTE CORP
Common Stock
S - Sale -6.582 16.979 -27,94 95,00 -625.290 1.613.005
2019-12-03 2019-12-02 4 INCY INCYTE CORP
Common Stock
M - Exercise 6.582 23.561 38,77 73,21 481.868 1.724.901
2019-12-03 2019-11-29 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -600 20.346 -2,86
2019-12-03 2019-11-29 4 INCY INCYTE CORP
Common Stock
S - Sale -600 16.979 -3,41 95,00 -57.000 1.613.005
2019-12-03 2019-11-29 4 INCY INCYTE CORP
Common Stock
M - Exercise 600 17.579 3,53 73,21 43.926 1.286.959
2019-11-26 2019-11-25 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -1.720 0 -100,00
2019-11-26 2019-11-25 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -422 20.000 -2,07
2019-11-26 2019-11-25 4 INCY INCYTE CORP
Common Stock
S - Sale -1.720 16.979 -9,20 90,00 -154.800 1.528.110
2019-11-26 2019-11-25 4 INCY INCYTE CORP
Common Stock
M - Exercise 1.720 18.699 10,13 48,44 83.317 905.780
2019-11-26 2019-11-25 4 INCY INCYTE CORP
Common Stock
S - Sale -422 16.979 -2,43 90,00 -37.980 1.528.110
2019-11-26 2019-11-25 4 INCY INCYTE CORP
Common Stock
M - Exercise 422 17.401 2,49 48,44 20.442 842.904
2019-11-14 2019-11-08 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
D - Sale to Issuer -20.000 0 -100,00
2019-11-14 2019-11-08 4 GHDX GENOMIC HEALTH INC
Common Stock
D - Sale to Issuer -397 0 -100,00
2019-10-03 2019-10-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 185 397 87,26 67,28 12.447 26.710
2019-09-19 2019-09-17 4 INCY INCYTE CORP
Common Stock
S - Sale X -2.491 16.757 -12,94 77,71 -193.576 1.302.186
2019-07-18 2019-07-17 4 INCY INCYTE CORP
Common Stock
S - Sale X -959 19.248 -4,75 79,91 -76.634 1.538.108
2019-07-16 2019-07-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -430 20.207 -2,08 81,39 -34.998 1.644.648
2019-07-09 2019-07-05 4 INCY INCYTE CORP
Common Stock
F - Taxes -273 20.637 -1,31 85,28 -23.281 1.759.923
2019-07-03 2019-07-02 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 16.428 16.428
2019-07-03 2019-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -417 20.910 -1,96 85,01 -35.449 1.777.559
2019-07-03 2019-07-02 4 INCY INCYTE CORP
Common Stock
A - Award 6.761 21.327 46,42
2019-07-03 2019-07-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 212 212 58,86 12.478 12.478
2019-04-18 2019-04-16 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 20.000 20.000
2019-02-19 2019-02-14 4 INCY INCYTE CORP
Common Stock
A - Award 5.389 14.333 60,25
2019-01-30 2019-01-28 4 INCY INCYTE CORP
Common Stock
S - Sale X -1.000 8.944 -10,06 80,00 -80.000 715.520
2019-01-10 2019-01-08 4 INCY INCYTE CORP
Common Stock
S - Sale X -1.714 9.944 -14,70 75,56 -129.510 751.369
2019-01-08 2019-01-07 4 INCY INCYTE CORP
Common Stock
F - Taxes -896 11.658 -7,14 74,21 -66.492 865.140
2019-01-08 2019-01-04 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 63.105 63.105
2019-01-08 2019-01-04 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 22.772 22.772
2018-10-05 2018-10-03 4 INCY INCYTE CORP
Common Stock
S - Sale X -1.000 12.427 -7,45 70,00 -70.000 869.890
2018-07-18 2018-07-16 4 INCY INCYTE CORP
Common Stock
F - Taxes -430 13.427 -3,10 70,19 -30.182 942.441
2018-07-05 2018-07-05 4 INCY INCYTE CORP
Common Stock
F - Taxes -273 13.857 -1,93 68,28 -18.640 946.156
2018-07-05 2018-07-02 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 22.772 22.772
2018-02-22 2018-02-20 4 INCY INCYTE CORP
Common Stock
F - Taxes -1.026 13.823 -6,91 86,03 -88.267 1.189.193
2018-01-25 2018-01-23 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 12.128 12.128
2017-09-15 2017-09-14 4 INCY INCYTE CORP
Common Stock
S - Sale X -714 14.782 -4,61 124,25 -88.714 1.836.664
2017-09-15 2017-09-13 4 INCY INCYTE CORP
Common Stock
F - Taxes -674 15.496 -4,17 123,15 -83.003 1.908.332
2017-07-07 2017-07-05 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 779 779
2017-07-07 2017-07-05 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 11.349 11.349
2017-07-07 2017-07-05 4 INCY INCYTE CORP
Common Stock
A - Award 3.517 16.170 27,80
2017-05-02 2017-05-01 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -2.064 1.720 -54,55
2017-05-02 2017-05-01 4 INCY INCYTE CORP
Common Stock
S - Sale -4.493 12.653 -26,20 124,75 -560.502 1.578.462
2017-05-02 2017-05-01 4 INCY INCYTE CORP
Common Stock
S - Sale -803 17.146 -4,47 124,61 -100.062 2.136.563
2017-05-02 2017-05-01 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.064 17.949 12,99 48,44 99.980 869.450
2017-02-28 2017-02-24 4 INCY INCYTE CORP
Common Stock
F - Taxes -2.473 15.743 -13,58 121,95 -301.582 1.919.859
2017-02-28 2017-02-14 4 INCY INCYTE CORP
Common Stock
A - Award 6.966 18.216 61,92
2017-01-19 2017-01-17 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 19.091 19.091
2016-10-11 2016-10-07 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -21.796 20.422 -51,63
2016-10-11 2016-10-07 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -2.408 3.784 -38,89
2016-10-11 2016-10-07 4 INCY INCYTE CORP
Common Stock
S - Sale X -24.204 11.187 -68,39 97,00 -2.347.788 1.085.139
2016-10-11 2016-10-07 4 INCY INCYTE CORP
Common Stock
M - Exercise 21.796 35.391 160,32 48,44 1.055.798 1.714.340
2016-10-11 2016-10-07 4 INCY INCYTE CORP
Common Stock
M - Exercise 2.408 13.595 21,52 48,44 116.644 658.542
2016-07-19 2016-07-15 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 596 596
2016-07-19 2016-07-15 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 18.495 18.495
2016-07-19 2016-07-15 4 INCY INCYTE CORP
Common Stock
A - Award 5.555 11.187 98,63
2016-01-08 2016-01-07 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 1.044 1.044
2016-01-08 2016-01-07 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 2.995 2.995
2016-01-08 2016-01-07 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 1.108 1.108
2016-01-08 2016-01-07 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 17.676 17.676
2016-01-08 2016-01-07 4 INCY INCYTE CORP
Common Stock
A - Award 2.610 5.632 86,37
2015-01-09 2015-01-08 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 599 599
2015-01-09 2015-01-08 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 20.946 20.946
2015-01-09 2015-01-08 4 INCY INCYTE CORP
Common Stock
A - Award 3.022 3.022
2014-08-13 2014-08-11 4 INCY INCYTE CORP
Non-Qualified Stock Options (right to buy)
A - Award 42.218 42.218
2014-08-13 2014-08-11 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
A - Award 6.192 6.192
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)